MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617064846 A) filed by Philochem AG on May 22, 2026, for Acid Phosphatase 3 Ligands For Targeted Delivery Applications.
Inventors include Cazzamalli, Samuele; Georgiev, Tony; Oehler, Sebastian; Migliorini, Francesca; Neri, Dario; and Park Kim, Young Seo.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: The present invention relates to ligands against Acid Phosphatase 3 (ACP3 or ACPP), also known as Prostatic Acid Phosphatase (PAP). Selective ACP3 ligands may be able to exclusively interact with antigens expressed on the surface of tumor cells for in vivo pharmaco-delivery applications. The ligand may display very high affinity and selectivity towards ACP3 to enable targeted delivery of a payload, including therapeutic and diagnostic payloads, to a site afflicted by or at risk of a disease characterized by the expression of ACP3.
Disclaimer: Curated by HT Syndication.
